Molecular analysis of cell free circulating DNA (cfDNA) and/or circulating tumour cells (CTC) as 'liquid biopsy' for predictive biomarker assessment in patients with metastatic colorectal cancer (mCRC).

The objective of this research project is to evaluate the clinical significance of mutation analysis on circulating free DNA and circulating tumour cells (CTC), shedded directly from the actually present tumour mass into the bloodstream, as an alternative for the archival tumour biopsy in patients with KRAS wild type mCRC.

Keywords:COLORECTAL CANCER, BIOMARKER, ONCOLOGY

Disciplines:Morphological sciences, Oncology

Project type:Collaboration project